Publications

Park, J.-H., Kim, S.-J., Cho, S. J., Kwon, S.-H., Kang, D.-W., & Lee, E.-K. (2026). Age-Specific Patterns in Utilization and Costs of Developmental Rehabilitation Therapy for Children With Autism Spectrum Disorder in South Korea: A Cross-Sectional Survey. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-026-07254-y

Oh, B. C., Cho, D. H., Choi, J., Kwon, S. H., & Yoo, B. S. (2025). Real-World Cost-Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure With Reduced Ejection Fraction in Korea. Korean Circ J, 55. https://doi.org/10.4070/kcj.2024.0403

Min, S., Won, Y. K., Kwon, S. H., & Lim, D. H. (2025). Cost-benefit analysis of a trifocal intraocular lens versus a monofocal intraocular lens in South Korea. Sci Rep, 15(1), 17330. https://doi.org/10.1038/s41598-025-00712-0

Min, S., Kwon, S. H., Seo, J. H., Nam, J. H., Park, J. H., Kwon, T., Kang, H. R., Ng, C., & Lee, E. K. (2025). Predictive model of public health impact of herpes zoster vaccination and related costs for adults aged >/=50 years in Republic of Korea. Hum Vaccin Immunother, 21(1), 2554488. https://doi.org/10.1080/21645515.2025.2554488

Kwon, S. H., Park, J. K., Baek, H. J., Nam, J. H., Min, S., Cho, A. R., Jung, A., & Park, Y. S. (2025). Burden of Haemophilia A in South Korea: A Serial Cross-Sectional Study From 2008 to 2021. Haemophilia, 31(4), 687-695. https://doi.org/10.1111/hae.70064

Tappenden, P., Hardiman, O., Kwon, S. H., Mon-Yee, M., Galvin, M., McDermott, C., & Group, A. L.-C. S. (2024). A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health Technologies. PharmacoEconomics, 42(9), 1003-1016. https://doi.org/10.1007/s40273-024-01395-7

Park, H., Yoon, E. L., Kim, M., Kwon, S. H., Kim, D., Cheung, R., Kim, H. L., & Jun, D. W. (2024). Cost-effectiveness study of FIB-4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at-risk population. Liver Int, 44(4), 944-954. https://doi.org/10.1111/liv.15838 

Min, S., Kwon, S. H., Lee, E. K., & Nam, J. H. (2024). Cost-effectiveness of improving patients' adherence to tuberculosis treatment in South Korea using discrete event simulation. J Infect Public Health, 17(3), 478-485. https://doi.org/10.1016/j.jiph.2024.01.002

Lee, J. E., Nam, J. H., Kwon, S. H., Kim, B. K., & Ha, S. M. (2024). Real-world evidence of brigatinib as second-line treatment after crizotinib for ALK+ non-small cell lung cancer using South Korean claims data (K-AREAL). Cancer Med, 13(14), e70030. https://doi.org/10.1002/cam4.70030

Jung, H. I., Kwon, S. H., Nam, J. H., Cho, J. Y., & Lee, E. K. (2024). Real-world effectiveness of CDK4/6 inhibitors on patients with HR+/HER2- advanced breast cancer in South Korea, focusing on underrepresented patients. Curr Med Res Opin(just-accepted), 1-9. https://doi.org/10.1080/03007995.2024.2349741

Cho, J. Y., Kwon, S. H., Lee, J. S., Lee, J., Lee, J. H., Chae, Y., & Lee, E. K. (2024). Factors associated with COVID-19 vaccination rates in countries with different income levels: a panel analysis. BMC Public Health, 24(1), 3538. https://doi.org/10.1186/s12889-024-20973-0

Chae, Y., Kwon, S. H., Nam, J. H., Kang, E., Im, J., Kim, H. J., & Lee, E. K. (2024). Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis. Expert Rev Clin Pharmacol, 17(8), 721-729. https://doi.org/10.1080/17512433.2024.2363838

Park, H. Y., Kwon, J. W., Kim, H. L., Kwon, S. H., Nam, J. H., Min, S., Oh, I. S., Bea, S., & Choi, S. H. (2023). Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens. J Korean Med Sci, 38(21), e167. https://doi.org/10.3346/jkms.2023.38.e167 

Park, H., Yoon, E. L., Kim, M., Kwon, S. H., Jun, D. W., & Kim, H. L. (2023). Letter to the Editor: Is lifestyle modification effective for individuals with high fibrosis-4 index without an additional second-tier test? Hepatology, 78(3), E59-E60. https://doi.org/10.1097/HEP.0000000000000512

Oh, B. C., Cho, A. R., Nam, J. H., Yang, S. Y., Kim, M. J., Kwon, S. H., & Lee, E. K. (2023). Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements. BMC Cancer, 23(1), 482. https://doi.org/10.1186/s12885-023-10950-y

Na, H., Kwon, S. H., Son, K. H., Baek, Y., Kim, J., & Lee, E. K. (2023). Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis. BioDrugs, 37(2), 205-218. https://doi.org/10.1007/s40259-023-00576-8 

Min, S., Kwon, S. H., Lee, Y. W., Lee, J. M., Bae, E. J., & Lee, E. K. (2023). Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea. Vaccines (Basel), 11(5), 984. https://doi.org/10.3390/vaccines11050984 

Lee, J. E., Kwon, S. H., Kwon, S., Jung, H. I., Nam, J. H., & Lee, E. K. (2023). Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer. JAMA Netw Open, 6(7), e2324852. https://doi.org/10.1001/jamanetworkopen.2023.24852

Yang, S. Y., Kang, D. W., Nam, J. H., Choi, E. K., Lee, E. K., Shin, J. Y., & Kwon, S. H. (2022). Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation. Sci Rep, 12(1), 3413. https://doi.org/10.1038/s41598-022-07316-y 

Son, K. H., Kwon, S. H., Na, H. J., Baek, Y., Kim, I., & Lee, E. K. (2022). Quantitative Benefit-Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis. Vaccines (Basel), 10(12), 2029. https://doi.org/10.3390/vaccines10122029

Oh, B. C., Lee, J. E., Nam, J. H., Hong, J. Y., Kwon, S. H., & Lee, E. K. (2022). Health-related quality of life in adult patients with asthma according to asthma control and severity: A systematic review and meta-analysis [Systematic Review]. Front Pharmacol, 13, 908837. https://doi.org/10.3389/fphar.2022.908837

Kwon, S. H., Nam, J. H., Kim, H. L., Park, H. Y., & Kwon, J. W. (2022). Real-world association of adherence with outcomes and economic burden in patients with tuberculosis from South Korea claims data [Original Research]. Front Pharmacol, 13, 918344. https://doi.org/10.3389/fphar.2022.918344

Jang, S. C., Oh, B. C., Nam, J. H., Lee, E. K., Kim, H. L., & Kwon, S. H. (2022). Clinical impact and economic burden of post-transplant infections following heart transplantation: A retrospective nationwide cohort study. J Heart Lung Transplant, 41(11), 1601-1610. https://doi.org/10.1016/j.healun.2022.08.001

Jang, S. C., Nam, J. H., Lee, S. A., An, D., Kim, H. L., Kwon, S. H., & Lee, E. K. (2022). Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis. Orphanet J Rare Dis, 17(1), 262. https://doi.org/10.1186/s13023-022-02425-3

Jang, S. C., Kwon, S. H., Min, S., Jo, A. R., Lee, E. K., & Nam, J. H. (2022). Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System. Front Pharmacol, 13, 906211. https://doi.org/10.3389/fphar.2022.906211

Cho, J. Y., Won, Y. K., Park, J., Nam, J. H., Hong, J. Y., Min, S., Kim, N., Chung, T. Y., Lee, E. K., Kwon, S. H., & Lim, D. H. (2022). Visual Outcomes and Optical Quality of Accommodative, Multifocal, Extended Depth-of-Focus, and Monofocal Intraocular Lenses in Presbyopia-Correcting Cataract Surgery: A Systematic Review and Bayesian Network Meta-analysis. JAMA Ophthalmol, 140(11), 1045-1053. https://doi.org/10.1001/jamaophthalmol.2022.3667

Park, H., Park, C. M., Woo, J. M., Shin, J. Y., Lee, E. K., & Kwon, S. H. (2021). Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants. J Med Econ, 24(1), 589-597. https://doi.org/10.1080/13696998.2021.1918922 

Kwon, S. H., Park, H. S., Na, Y. J., Park, C., Shin, J. Y., & Kim, H. L. (2021). Price Reduction of Anticancer Drugs from 2007 to 2019 in South Korea: The Impact of Pharmaceutical Cost-Containment Policies. Appl Health Econ Health Policy, 19(3), 439-450. https://doi.org/10.1007/s40258-020-00604-6

Hong, S. H., Cho, J. Y., Kim, T. B., Lee, E. K., Kwon, S. H., & Shin, J. Y. (2021). Cost-Effectiveness of Tiotropium in Elderly Patients with Severe Asthma Using Real-World Data. J Allergy Clin Immunol Pract, 9(5), 1939-1947 e1937. https://doi.org/10.1016/j.jaip.2020.11.052

Cho, J. Y., Kwon, S. H., Lee, E. K., Lee, J. H., & Kim, H. L. (2021). Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data. Front Oncol, 11, 728740. https://doi.org/10.3389/fonc.2021.728740

Byun, J. Y., Kim, H. L., Lee, E. K., & Kwon, S. H. (2021). A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments. Front Pharmacol, 12, 736986. https://doi.org/10.3389/fphar.2021.736986

Yang, S. Y., Park, S. K., Kang, H. R., Kim, H. L., Lee, E. K., & Kwon, S. H. (2020). Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis. BMJ Support Palliat Care. https://doi.org/10.1136/bmjspcare-2020-002453 

Yang, S. Y., Jung, H. D., Kwon, S. H., Lee, E. K., Lee, J. Y., & Lee, S. H. (2020). Does Early Retrograde Intrarenal Surgery Improve the Cost-Effectiveness of Renal Stone Management? Yonsei Med J, 61(6), 515-523. https://doi.org/10.3349/ymj.2020.61.6.515

Park, J. A., Lee, M. Y., Nam, J. H., Shin, J. Y., Wood, R., Holbrook, T., & Kwon, S. H. (2020). Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South Korea. Curr Med Res Opin, 36(2), 343-351. https://doi.org/10.1080/03007995.2019.1688271

Lee, Y. J., Kwon, S. H., Hong, S. H., Nam, J. H., Song, H. J., Lee, J. S., Lee, E. K., & Shin, J. Y. (2017). Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database. Clin Ther, 39(3), 527-536. https://doi.org/10.1016/j.clinthera.2017.01.025 

Kwon, S. H., Park, S. K., Byun, J. H., & Lee, E. K. (2017). Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea. Expert Rev Pharmacoecon Outcomes Res, 17(4), 411-419. https://doi.org/10.1080/14737167.2017.1277144

Byun, J. H., Kwon, S. H., Lee, J. E., Cheon, J. E., Jang, E. J., & Lee, E. K. (2016). Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments. Patient Prefer Adherence, 10, 641-650. https://doi.org/10.2147/PPA.S98228 

Byun, J. H., Kwon, S. H., Ha, J. H., & Lee, E. K. (2016). A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients. Ther Clin Risk Manag, 12, 965-974. https://doi.org/10.2147/TCRM.S100438

Kim, H. L., Lee, M. Y., Park, S. Y., Park, S. K., Byun, J. H., Kwon, S., & Lee, E. K. (2014). Comparative effectiveness of cycling of tumor necrosis factor-alpha (TNF-alpha) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-alpha inhibitor using a Bayesian approach. Arch Pharm Res, 37(5), 662-670. https://doi.org/10.1007/s12272-014-0337-1 

Kwon, S.-H., Kim, J. S., Nam, J. H., & Lee, E.-K. (2025). Identification of Confounders Using Network Analysis: A Case Study in Patients with Atrial Fibrillation. Yakhak Hoeji, 69(6), 565-573. 

Kim, H.-L., Kwon, S.-H., & Nam, J. H. (2025). Continuity of Care and Its Impact on the Topical Medication Persistence and Medical Costs in Patients with Glaucoma. Korean Journal of Clinical Pharmacy, 35(1), 23-30. https://doi.org/10.24304/kjcp.2025.35.1.23 

Choi, H., Sohn, H. S., Kwon, S.-H., Im, S.-B., Lee, J., & Kim, H.-L. (2025). Perceptions of Additional Costs for Community Pharmacy Services and their Determinants in the General population in Korea. Yakhak Hoeji, 69(2), 180-191. https://doi.org/10.17480/psk.2025.69.2.180 

Cha, Y.-S., An, E.-J., Kwon, S.-H., & Lee, E.-K. (2024). Immunogenicity of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine on the Prevention of Influenza Virus: A Systematic Review and Meta-analysis. Yakhak Hoeji, 68(1), 71-78. 

최한실, 권순홍, 황태원, & 이진형. (2024). 지역약국 신규 도입 서비스에 대한 재정 분석. 한국보건사회연구, 44(2), 108-128. 

Lee, Y.-W., Kwon, S.-H., Kim, N.-H., & Lee, E.-K. (2022). Cost-effectiveness of Combination Therapy of Anticoagulants/antiplatelets with Proton Pump Inhibitors: A Systematic Review [KCI]. Yakhak Hoeji, 66(5), 292-301. https://doi.org/10.17480/psk.2022.66.5.292 

Park, N., Min, S., Shon, Y. H., Nam, J. H., & Kwon, S.-H. (2021). Regulations and Guidelines for Therapeutic Approval of Investigational Drugs [KCI]. Yakhak Hoeji, 65(6), 441-452. 

Oh, B.-C., Cho, J.-Y., Kwon, S.-H., Lee, E.-K., & Kim, H.-L. (2021). Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data [KCI]. Korean Journal of Clinical Pharmacy, 31(2), 153-159. https://doi.org/10.24304/kjcp.2021.31.2.153 

Kwon, S.-H., Sohn, E.-H., & Kim, H.-L. (2021). A Comparative Study on Health Insurance Fees Related to Community Pharmacists’ Services in Korea and Japan [KCI]. Yakhak Hoeji, 65(1), 10-16. 

Jang, S.-C., Lee, S.-W., & Kwon, S.-H. (2020). National Research and Development Trends related to Safety Evaluation Technology of Biologics and Chemical Synthetic Drug: A Network Analysis [KCI]. Yakhak Hoeji, 64(4), 290-298. 

하소영, 곽민주, & 권순홍. (2020). 건강보험 청구자료를 이용한 트라마돌 안전성 관련 사전예고 전후 소아환자 대상입원 및 외래 처방현황 분석 [KCI]. 약학회지, 64(6), 454-460. 

양소영, 장선미, 권순홍, 이주연, 아영미, 강신우, 홍성현, & 박혜경. (2020). 올바른 약물 이용 지원 시범사업 성과 연구 [KCI]. 보건사회연구, 40(3), 563-591. 

SH, K., JH, L., JH, L., & EK, L. (2017). Estimating the price elasticity of demand for off-patent prescription drugs [KCI]. Health Soc Res, 37(2), 577-601.